RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 111 filers reported holding RECRO PHARMA INC in Q4 2019. The put-call ratio across all filers is 1.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,992,888 | -39.6% | 4,249,229 | +41.7% | 0.03% | -38.1% |
Q2 2023 | $3,299,152 | -7.6% | 2,999,229 | 0.0% | 0.04% | -16.0% |
Q1 2023 | $3,569,083 | -16.4% | 2,999,229 | +4.7% | 0.05% | -21.9% |
Q4 2022 | $4,268,558 | +1642.3% | 2,864,804 | +9449.3% | 0.06% | +700.0% |
Q1 2020 | $245,000 | -93.3% | 30,000 | -84.9% | 0.01% | -91.8% |
Q4 2019 | $3,648,000 | – | 199,000 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samjo Capital LLC | 8,039,100 | $3,770,338 | 1.48% |
First Light Asset Management, LLC | 19,676,396 | $9,228,230 | 0.88% |
AWM Investment Company, Inc. | 10,266,144 | $4,814,822 | 0.71% |
Caligan Partners LP | 1,689,768 | $794,191 | 0.36% |
HighMark Wealth Management LLC | 484,985 | $227,458 | 0.19% |
Nantahala Capital Management | 1,250,000 | $586,250 | 0.05% |
Clear Harbor Asset Management, LLC | 938,847 | $440,319 | 0.05% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 4,249,229 | $1,992,888 | 0.03% |
TITLEIST ASSET MANAGEMENT, LLC | 210,148 | $98,559 | 0.02% |
ROYCE & ASSOCIATES LP | 3,285,082 | $1,540,703 | 0.02% |